Last update: Feb. 1, 2017

Sucralfate

Very Low Risk for breastfeeding


Safe. Compatible.
Not risky for breastfeeding or infant.

It is a glycoside-sulphate derivative (sucrose) plus aluminum.



At latest update no published data on excretion into breastmilk were found.



Pharmacokinetic data (virtually non-absorbed with a high molecular weight) make it very unlikely the excretion into breastmilk in significant amounts, which in addition it would not be absorbed through the infant's intestine.



Medication with authorized use on infants.

Alternatives

We do not have alternatives for Sucralfate since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Sucralfate in other languages or writings:

Group

Sucralfate belongs to this group or family:

Tradenames

Main tradenames from several countries containing Sucralfate in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. < 5 %
Molecular weight 2087 daltons

References

  1. Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006 Jul;131(1):283-311. Review. Abstract Full text (link to original source) Full text (in our servers)
  2. Richter JE. Review article: the management of heartburn in pregnancy. Aliment Pharmacol Ther. 2005 Nov 1;22(9):749-57. Review. Abstract Full text (in our servers)
  3. Hagemann TM. Gastrointestinal medications and breastfeeding. J Hum Lact. 1998 Sep;14(3):259-62. Review. Abstract
  4. Broussard CN, Richter JE. Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options? Drug Saf. 1998 Oct;19(4):325-37. Review. Abstract

Total visits

18,904

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche de México from Mexico

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM